Emanuel Raschi

73PUBLICATIONS

71CO-AUTHORS

Molecular targetsInstrumental methods (excl. immunological and bioassay methods)NeonatologyPharmacology and pharmaceutical sciences not elsewhere classifiedSurface water quality processes and contaminated sediment assessment

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (73)

Sort by Publication Date:

|Jun 05, 2026

Major Adverse Cardiac Events with Ondansetron: The Role of Observational Evidence to Inform Actionable Safer Prescribing in Cardio-Oncology.

|May 05, 2026

Reply to "A Comment about AI Methods that May Help Advance Pharmacovigilance".

|May 04, 2026

Low-Volume Polyethylene Glycol for Bowel Preparation in Hospitalized Adults : A Multicenter Randomized Trial.

|Dec 21, 2025

The Rising Misuse of Pharmacovigilance Reporting Systems: A Threat to Evidence-Based Medicine.

Charles Khouri, Alex Hlavaty, Michele Fusaroli

|Aug 20, 2025

FDA Adverse Event Reporting System Essentials: A Reflection on Study Conception.

Emanuel Raschi, Paola Cutroneo, Francesco Salvo

|Jun 16, 2025

Letter to the Editor From Raschi et al: "Endocrine Adverse Reactions of Tyrosine Kinase Inhibitors in Combination With Immune Checkpoint Inhibitors".

Emanuel Raschi, Monia Donati, Francesco Salvo

Pageof 13

Frequent Collaborators

19 joint publications

Fabrizio De Ponti

16 joint publications

Elisabetta Poluzzi

13 joint publications

Michele Fusaroli

Milo Gatti

Charles Khouri

Carlotta Lunghi

Francesco Salvo

Igor Diemberger

Valentina Giunchi

Gian Paolo Fadini

Frequent Collaborators

19 joint publications

Fabrizio De Ponti

16 joint publications

Elisabetta Poluzzi

13 joint publications

Michele Fusaroli

9 joint publications

Milo Gatti